Glick Gary D
SEC insider (Form 3/4/5 filer). CIK 0002051249. Director at Odyssey Therapeutics, Inc. (ODTX). 2 reported Form 4/5 transactions since Sep 2024; latest on May 11, 2026. Located in BOSTON, MA.
Companies Glick Gary D has filed insider reports for
- Odyssey Therapeutics, Inc. (ODTX): Director, Officer, See Remarks
Glick Gary D
CIK: 0002051249
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ODTX
Odyssey Therapeutics, Inc.
DirectorOfficer